Market Estimates
Valuation Metrics
Financials
Trading Trends
INM News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is InMed Pharmaceuticals Inc (INM) stock price today?
The current price of INM is 1.2 USD — it has increased 6.19 % in the last trading day.
What is InMed Pharmaceuticals Inc (INM)'s business?
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
What is the price predicton of INM Stock?
Wall Street analysts forecast INM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is InMed Pharmaceuticals Inc (INM)'s revenue for the last quarter?
InMed Pharmaceuticals Inc revenue for the last quarter amounts to 1.12M USD, decreased -11.43 % YoY.
What is InMed Pharmaceuticals Inc (INM)'s earnings per share (EPS) for the last quarter?
InMed Pharmaceuticals Inc. EPS for the last quarter amounts to -0.44 USD, decreased -99.19 % YoY.
What changes have occurred in the market's expectations for InMed Pharmaceuticals Inc (INM)'s fundamentals?
How many employees does InMed Pharmaceuticals Inc (INM). have?
InMed Pharmaceuticals Inc (INM) has 13 emplpoyees as of January 07 2026.
What is InMed Pharmaceuticals Inc (INM) market cap?
Today INM has the market capitalization of 3.17M USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F5b4235108ef775d5f7e8fe7bb32f8152c6d98e98154019606960dfc65769bb3b.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F61f6920d35338397b7a0b32055449e389c356b82f25290bcdfc26299a21e37ed.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F7cd9982ddbe626c3d090bd1500ad1b7fe8bdb1f766c307dd36ba361b7f0124b2.png&w=384&q=75)